Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eunice Wang, MD
Roswell Park Cancer Institute, Buffalo, New York, United States, 14263
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- Hospital Avicenne
Bobigny, France
- Chu Grenoble Alpes
Grenoble, France
- Hospital Center of Versailles (le Chesnay)
Le Chesnay, France
- Hospital Claude Huriez - Chru Lille
Lille, France
- Institut Paoli-Calmettes
Marseille, France
- Chu de Nantes - Hôtel Dieu
Nantes, France
- University Hospital Nice L'Archet
Nice, France
- Hôpital St Louis
Paris, France
- Chu de Bordeaux
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Chu de Poitiers
Poitiers, France
- Institut Universitaire Du Cancer Toulouse
Toulouse, France
- Klinikum Chemnitz Ggmbh
Chemnitz, Germany
- Technische Universität Dresden
Dresden, Germany
- Universitätsklinikum Essen (aör)
Essen, Germany
- Universitätsklinikum Frankfurt
Frankfurt, Germany
- Universitätsklinikum Halle (saale)
Halle, Germany
- Universitätsklinikum Münster
Münster, Germany
- Policlinico Tor Vergata
Roma, RM, Italy
- Aou Policlinico Sant'Orsola-Malpighi
Bologna, Italy
- Asst Spedali Civili Di Brescia
Brescia, Italy
- Aou Careggi
Florence, Italy
- Irst - Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori
Meldola, Italy
- Irccs Foundation Ca 'Granda Ospedale Maggiore Policlinico
Milan, Italy
- Irccs San Raffaele Hospital
Milan, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Aou Federico Ii
Naples, Italy
- Aorn Antonio Cardarelli
Naples, Italy
- Aou Maggiore Della Carità
Novara, Italy
- Ao Ospedali Riuniti Villa Sofia-Cervello
Palermo, Italy
- Ao Ospedali Riuniti Marche Nord
Pesaro, Italy
- Ospedale Santa Maria Delle Croci Di Ravenna
Ravenna, Italy
- Fondazione Policlinico Universitario Agostino Gemelli
Roma, Italy
- A.O.U. Città Della Salute E Della Scienza Di Torino
Torino, Italy
- Ao Ordine Mauriziano Di Torino
Torino, Italy
- Policlinico Gb Rossi, University Hospital Verona
Verona, Italy
- Aulss N 8 Berica Ospedale San Bortolo
Vicenza, Italy
- Hospital U. Virgen del Rocio
Seville, Andalusia, Spain
- Hospital U. Marques de Valdecilla
Santander, Cantabria, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Aug 2018
- Primary completion
- 3 Apr 2026
- Completion
- 3 Apr 2026
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 106
- Registry id
- NCT03250338
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.